Inari Medical (NARI) Faces DOJ Probe and Investor Backlash Amid Kickback Allegations – Hagens Berman

Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: NARI@hbsslaw.com 844-916-0895 Inari Medical, Inc. (NASDAQ: NARI), a leading medical device manufacturer, finds itself embroiled in a complex legal battle as the U.S. Department of Justice (DOJ) intensifies its scrutiny. The investigation centers on allegations of illicit kickbacks to healthcare professionals, a revelation that has sent shockwaves through the com ...